title: Denosumab improves bone mineral density and microarchitecture and reduces bone pain in women with osteoporosis with and without glucocorticoid treatment.
abstract: Osteoporosis is a key health problem in postmenopausal women with high social and economic impact. Decreased bone mineral density (BMD) and deterioration of bone microarchitecture may occur also as a result of long-term glucocorticoid treatment (GCT) of autoimmune or inflammatory conditions. Denosumab specifically inhibits the binding of the receptor activator of nuclear factor-κB to its ligand, thus preventing osteoclast activation and bone resorption. The efficacy and safety of denosumab, administered subcutaneously as 60 mg, once every six months for 12 months, were evaluated in 60 patients with postmenopausal osteoporosis (PMO) divided into two groups. The GCT group included 30 patients receiving concomitant glucocorticoid therapy and the non-GCT group included 30 patients that did not receive GCT. In the non-GCT group, the 12-month treatment with denosumab resulted in BMD increase of 6.1% and 2.8% in lumbar spine and hip, respectively. T-score increased by 13.1% and 5.6% in both, the lumbar spine and hip. A slight rise in the Trabecular Bone Score (TBS) of 0.3% was observed. Bone pain was markedly reduced by 56.2%. In the GCT group, denosumab therapy increased BMD with 5.8% and 2.3% in lumbar spine and hip, respectively. T-score of lumbar spine and hip significantly increased by 14.0% and 4.4%, and the TBS rose by 5%. Bone pain was reduced by 53.6%. These data confirm the available knowledge on denosumab efficacy and safety in women with PMO and also provide new insights into its therapeutic potential in patients with osteoporosis related to a long-term corticosteroid treatment.
authors.affiliation: Clinic of Rheumatology, Medical University , Sofia , Bulgaria.
authors.forename: Tzvetanka
authors.initials: T
authors.lastname: Petranova
authors.affiliation: Clinic of Rheumatology, Medical University , Sofia , Bulgaria.
authors.forename: Ivan
authors.initials: I
authors.lastname: Sheytanov
authors.affiliation: Clinic of Rheumatology, Medical University , Sofia , Bulgaria.
authors.forename: Simeon
authors.initials: S
authors.lastname: Monov
authors.affiliation: Rheumatology Center 'Sveta Irina' , Sofia , Bulgaria.
authors.forename: Rodina
authors.initials: R
authors.lastname: Nestorova
authors.affiliation: Clinic of Rheumatology, Medical University , Sofia , Bulgaria.
authors.forename: Rasho
authors.initials: R
authors.lastname: Rashkov
keywords: BMD; TBS; bone pain; denosumab; glucocorticoid treatment; postmenopausal osteoporosis